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ABSTRACT  
Innovations in health care are costly and risky, but they also provide the opportunity for 
hospitals to increase quality of care, to distinguish themselves from competitors and to 
attract patients. While numerous hospitals strive to increase their innovativeness by 
adopting a costly innovation leader strategy, the question of whether this actually 
influences the patient’s choice remains unanswered. To understand the role of 
innovativeness from the patient perspective, this study conceptualizes the construct of 
innovativeness reputation of hospitals and determines its relevance in patients’ hospital 
choice decisions. In the pretest, we identified six dimensions of innovativeness reputation 
such as progressive work procedures and value added services. We then used three 
different quantitative multi-criteria decision-making methods to evaluate the relative 
importance of innovativeness reputation in patient choice. We collected data from 355 
German former patients who had undergone elective non-emergency surgery. Overall, 
innovativeness reputation accounts for 11.6%-16.8% of the patient decision. 
Innovativeness reputation has a moderate influence on hospital choice and should be 
taken into account by managers. Since technical innovations are costly, hospitals should 
use other means to enhance their innovative image. Strategies such as emphasizing value 
added services can enable hospitals to increase efficiently their innovativeness reputation.  
Keywords: innovativeness reputation, hospital choice, conjoint analysis, analytic 
hierarchy process 
 1 
 
INTRODUCTION  
Innovation is a concept with positive connotations and is often associated with 
organizational success and societal progress. Over the last decades, innovation in the 
medical context has also proven to be an important driver of increased population health 
outcomes.1,2 From the health care providers’ point of view, building a reputation for being 
innovative can be a means to achieve strategic differentiation and a tool to attract patients 
in times of growing competition.2  
However, achieving a reputation for being innovative in health care can be 
challenging. Classic concepts of organizational innovation relate innovativeness to the 
adoption of innovations, which in the health care context implies high investments. For 
instance, different studies identified innovation as the main reason for increasing health 
care expenditures.3 Furthermore, high degrees of innovativeness imply a certain amount 
of risk taking.4 In this uncertain context, health care providers face the complex dilemma 
of balancing the benefits of innovation (i.e., improved health care quality and 
differentiation from competitors) against its downside (i.e., increased costs and risks).  
In order to provide further insights as to how this dilemma might be solved, we 
argue for the need to explore the role of hospital innovativeness reputation — the degree 
to which a hospital is perceived as innovative by its customers — as a strategic asset in 
patient choice. This aspect has remained unexplored, which is surprising in times of 
increasing competition, when the notion of hospitals as patient-centered service providers 
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and the patient as an empowered consumer with deliberate choice ability become salient. 
Attracting patients can be an important lever for hospital success and should be taken into 
account when hospital decision makers choose an innovation strategy.  
Our paper aims to address current gaps in the literature in two ways. First, 
organizational innovativeness is a prominent term in health care, but innovativeness has 
barely been considered from the patients’ viewpoint. Therefore, we aim at 
conceptualizing hospital innovativeness from the patient perspective. To do so, we rely 
on the literature on organizational reputation and conceive the patient’s perception as 
hospital innovativeness reputation. We explore this concept in a qualitative pretest and 
identify six dimensions of innovativeness reputation. Second, literature offers very little 
information about whether a hospital’s reputation for being innovative affects the choice 
of patients. The few previous studies that can be identified often directly ask patients 
about their preferences and therefore neglect the true nature of these decisions, which are 
trade-offs between factors. Therefore, we analyze what role innovativeness reputation 
plays in the multi-criteria decision situation of hospital choice.  
The remainder of the manuscript will provide an overview of the literature on 
hospital innovativeness, organizational reputation and hospital choice, followed by an 
explanation of the study’s methodology. Subsequently the results are presented and 
discussed. Finally, we provide practical implications and suggestions for further research. 
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THEORY 
Hospital Innovativeness 
The construct of hospital innovativeness is often considered to be one-
dimensional and exclusively related to the adoption of technical innovations. For 
example, Tabak & Jain (2000) define hospital innovativeness as top managers’ intention 
to adopt innovations.5 However, more recent literature has expanded the concept to 
include the hospital’s ability to adopt and generate innovations.6 Salge & Vera (2009) 
call for a reconceptualization of innovativeness to integrate a hospital’s capability to 
generate both science-based and practice-based innovations internally. Science-based 
innovativeness relates to clinical innovations by specialists and can be measured, for 
example, by publication output. Practice-based innovativeness describes internal practice 
innovations by a variety of staff members and can be measured by means of idea 
suggestion scores or related indicators.7 In addition, other researchers have shed light on 
other forms of innovation generation in hospital that are not related to technical or 
scientific aspects. For instance, novel routines that improve the orchestration of 
interactions between the patient and the health care organization can enhance both patient 
satisfaction and hospital performance.8 Therefore, different forms of internally generated 
innovativeness can be a lever to balance the tension between improved health outcomes 
and costs of health care.  
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We build on this literature, which takes a broader stance on the meaning of 
innovativeness within the health care context. Additionally, we further expand the 
reconceptualization of innovativeness to acknowledge that different actors within the 
health care system might have different views on the meaning and importance of 
innovativeness. Consumers observe several organizational activities and organizational 
characteristics over time to judge whether a firm (i.e., hospital) is innovative. From 
research on consumer perception of firm innovativeness, we know that consumers’ idea 
of innovativeness goes far beyond the mere availability of technical innovations. For 
instance, they also consider image factors such as whether the organization is dynamic 
and forward-looking.9 For example, from a classic organizational or firm perspective, a 
company such as Google is innovative because of its generation of (technical) innovations 
like Google Maps, Google Glasses or Google Translator. From a consumer perspective, 
Google could also be perceived as innovative because of its different workplace culture, 
the modern office spaces or the look and feel of its products. Previous research shows 
that innovativeness from the consumer perspective includes two dimensions: the 
perceived novelty of the firm’s activities and the perceived higher benefit of these 
activities compared to previous alternatives.9,10 Hence, a hospital that appears to be 
different from the standard and provides benefits compared to competitors should be 
recognized as being innovative. 
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However, until now research on consumers’ perceived firm innovativeness in 
general is sparse. More specifically to the health care context, prior literature has looked 
at hospital innovativeness mainly from the organization’s own perspective.11 Conversely, 
the patient view on hospital innovativeness is largely missing.  
This lack of attention to how patients evaluate the innovativeness of a hospital and 
whether it influences their hospital choice is a major gap for several reasons. First, as we 
explain in the section on hospital choice, a hospital’s success depends on patients 
choosing it for treatment. Second, the former understanding of patients as passive 
recipients of care now shifts to an understanding of patients as active co-creators of value, 
whose involvement in health services can enhance their own health outcomes.12 Third, 
improved information access transforms patients to empowered, knowledgeable 
consumers of health services.13 Hence, we argue for the need to apply a multidimensional 
conceptualization of hospital innovativeness reputation as a representation of the patient 
perspective.  
Organizational Reputation 
Organizational reputation signals stakeholders how an organization’s products 
and services perform compared to those of competitors.14 Stakeholders, such as 
consumers, derive the reputation from the organization’s historical behavior and 
associations.15,16 To this end, they rely on information originating from media, the 
organization itself (e.g., quality reports) or from narratives of others.14 Hence, when 
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patients have no previous experience with a hospital, they evaluate its characteristics 
based on the information they can gather from third parties.17 It is important to note that 
organizational reputation is perceptual and constitutes “an understanding of the 
organization as it exists in the minds of beholders”.15  
Reputation is a key concept for understanding firm success since it affects the 
organization’s relationships with stakeholders.15 If the reputation is favorable, the 
organization can attract consumers and can benefit from positive economic and market 
consequences.14 Reputation is particularly important to organizations in the health care 
context. Patients as consumers of hospital services often experience anxiety and stress. 
Hospitals are perceived as frightening places, where patients undergo treatment and do 
not enjoy themselves. Patients are therefore more emotional, sensitive and demanding 
than customers in other consumption settings.18 Under these conditions, patients are likely 
to rely on hospitals supported by favorable reputations, where discomfort and stress is 
expected to be minimized.  
In order to further define the nature of a hospital’s innovativeness reputation, we 
rely on the three dimensions of organizational reputation defined by Lange et al. (2011). 
First, being known refers to the generalized awareness, visibility and prominence of the 
organization. Second, being known for something entails the perception that the 
organization possesses a particular attribute of interest for the stakeholders (e.g., quality). 
Third, generalized favorability includes the overall judgment of the organization as good, 
 7 
 
attractive and appropriate.15 In the context of this article and in line with the 
conceptualization above, we refer to a hospital as having an innovativeness reputation, if 
the hospital is visible and favorably known for being innovative.  
Hospital Choice 
In many health care systems, hospitals have to compete for patients in order to 
obtain enough revenues and remain economically viable.19 The choice of a treatment 
facility is often made in a joint decision making process between the referring physician 
and the patient. However, as a result of a variety of health care reforms and the increasing 
salience of patient empowerment, the role of the patient in hospital choice decisions is 
becoming more dominant. Health care service providers increasingly realize that they 
have to address the patients’ needs and preferences to maintain their patient volume. It is 
therefore important to understand patients’ hospital choice criteria. When actively 
choosing a hospital, patients rely on available information such as observable hospital 
characteristics or third-party information.17,20 Previous research already analyzed a 
number of potential factors that influence patients’ hospital choice. The most important 
factors are prior experience, recommendations, information on quality indicators, 
distance and waiting time.17,20,21,22 However, despite the endeavor of many hospitals to 
create an innovative image and the tremendous costs associated with an innovation leader 
strategy, previous studies did not evaluate innovativeness as an antecedent of patients’ 
hospital choice. The approach of this study aims to close this gap by explicitly analyzing 
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the importance of innovativeness reputation of hospitals compared to other well 
researched factors in hospital choice.   
METHOD 
Pretest 
 Since no common conceptualization of innovativeness reputation in the context 
of hospitals exists, we conducted a qualitative pretest to explore the consumer’s 
perception of this construct. We interviewed 98 participants (average age 38 years 
(SD=16), 52% male and 48% female) in a face-to-face situation and asked them to answer 
the open-ended question: “On the basis of which criteria do you evaluate the 
innovativeness of a hospital?” We specifically chose this broad and open research 
question to reflect the lack of conceptualization previous literature provides in terms of 
consumer perception of innovativeness. Therefore, this pretest is designed to capture the 
full spectrum of innovativeness reputation regardless of previous concepts of classic non-
consumer based firm innovativeness.   
In October and November 2014, master-level students from a German university 
recruited interviewees from their immediate environment and conducted the interviews. 
The answers were initially written down by the interviewers. Subsequently, the authors 
conducted a content analysis with inductive coding and generated a category system with 
six dimensions of the construct hospital innovativeness reputation. These six dimensions 
of hospital innovativeness reputation and their sub-dimensions consider the adoption and 
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generation of different types of innovations: science-based product innovations (e.g., 'new 
technologies and medical devices'), practice-based service innovations (e.g., ‘high 
patient-centeredness’), process innovations (e.g., ‘efficient processes’) and 
organizational innovations (e.g., ‘high research orientation’). Table 1 presents a detailed 
overview of the characteristics that define each of the six dimensions, as well as the 
absolute and relative frequencies with which respondents mentioned them.  
__________________________ 
Insert Table 1 here 
__________________________ 
The dimensions and sub-dimensions reflect literature that defines perceived consumer 
innovativeness as the enduring capability and propensity of firms to generate and adopt 
something novel and beneficial.6,7,9,10 The first two dimensions closely reflect traditional 
conceptualizations of innovativeness related to the provision of high standards for patient 
treatment and of complementary patient services. The remaining four dimensions show 
that patients’ evaluation of innovativeness reputation is broader but can be consistently 
related to the concepts of novelty and additional benefits. For example, a ‘pleasant 
architecture’, which includes among others a contemporary interior design and a pleasant 
ambience, is perceived as innovative by consumers because hospitals often lack these 
features (i.e., novelty) and it provides additional benefits such as being comforting and 
calming or having a positive influence on patients’ mood (i.e., benefit). Moreover, the 
dimension ‘efficient organization’ indicates that, for patients, innovative hospitals are not 
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only technological forerunners in medical methods but also in technological and 
organizational management tools (e.g., digital data transfer or critical incident reporting 
system). Such innovative management tools are not yet a standard in hospitals from the 
patient perspective (i.e., novelty), but can result in better patient outcomes. For example, 
the digital interconnectedness between infirmaries in a hospital avoids that the patients 
have to repeatedly explain their symptoms and medical history to different physicians and 
ensures that no relevant diagnostic by a physician is unavailable to a subsequent physician 
in the treatment procedure of the patient (i.e., benefit). Finally, the dimensions ‘competent 
staff’ and ‘innovative stakeholder communication’ might not be an innovation in the 
traditional understanding based on the firm perspective. However, from the patient’s 
perspective, an extra attention to the appearance of staff members and information access, 
among others, might be unusual for hospitals (i.e., novelty) and perceived as indicator for 
professionalism and consequently good service (i.e., benefit). 
 
Methodological Approach 
We investigated the relative importance of innovativeness reputation in patients’ 
hospital choices with quantitative multi-criteria decision-making methods. These 
methods can be classified as compositional or decompositional. Analytic hierarchy 
process (AHP) and conjoint analysis (CA) are respectively popular methods within these 
two categories and broadly applied in decision analysis. Compositional methods ask 
questions about attributes to estimate preferences, while decompositional methods ask for 
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general judgments on multi-attribute alternatives.23 AHP is less complex to apply in 
practice and performs better concerning validity indicators, whereas CA uses a more 
realistic setting.23  
In addition, each participant directly reported their preferences on a constant sum 
scale. Because the results of the direct and indirect measurement of preferences may 
differ,22 the use of AHP, CA and constant sum scale allows our study to uncover and 
discuss such differences.  
Participants 
We recruited participants with the help of master-level students from a German 
university in December 2014 and January 2015. We trained the students in data collection 
methods and provided quota plans to ensure equal distribution between genders and a 
sufficient amount of study participants in different age groups.  
To ensure that the participants were able to reflect on a real context, they had to 
have undergone an elective non-emergency surgery within the last two years and made a 
deliberate hospital choice without limitations. The setting is particularly suitable for this 
study since the German health care system generally allows freedom of hospital choice. 
Each of the 80 students had to recruit at least four participants who fulfilled this 
requirement, through snowball sampling.  
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Quantitative Multi-Criteria Decision Making 
Hospital Choice Attributes 
To determine the relative importance of innovativeness reputation, we provided the 
participants with a realistic choice situation where we selected hospital attributes that 
previous research found to be most relevant. We limited the number of attributes to five, 
which has been argued to be the maximum number that patients can effectively process.20 
To make the results comparable, we included the same five attributes in the different 
methodological approaches. Based on previous literature,20,21,22 we selected the attributes 
distance, recommendation (from physicians or family), waiting time, and quality 
information in addition to innovativeness (i.e., the term we used in front of participants 
to refer to innovativeness reputation,). Other relevant attributes reported in the literature, 
such as shared decision making, are included in our conceptualization of innovativeness 
reputation of hospitals and were not considered separately to minimize inter-attribute 
correlation.  
We followed the approach of Leister & Stausberg (2007) and excluded prior 
hospital experience.24 Previous research has shown that prior experience is the most 
relevant choice criterion20,21 and would dominate all other criteria. Excluding experience 
is aligned with our aim of understanding the importance of attributes where no 
experiential knowledge is available and the choice is based on direct hospital information 
or third-party information.  
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For recommendation and innovativeness, we used a binary measure that reflects a 
high or low value (i.e., recommended vs. not recommended, high vs. low innovativeness). 
For the attributes distance, waiting time and quality information, we determined threshold 
values. Distance values (i.e., near=30 minutes vs. far=1.5 hours with means of transport) 
were determined based on the average distance to the closest hospital in Germany (3-9 
km)25 and usual travel times to them in an urban area (<20 minutes for 98% of the 
population). Similarly, values for waiting time (i.e., short=2 months vs. long=6 months) 
for non-emergency surgery procedures were based on averages. The shortest mean 
waiting times in OECD countries are below 45 days and the longest mean waiting times 
are five months.26 We used infection rates as proxy for quality information21 (i.e., 
infection rate low=1.8% vs. high=4.7%) as nosocomial infection rates are among the most 
important choice criteria.27 The average prevalence of hospital-associated infections is 
5% for surgery in Germany and less than 1% for hip and knee surgery. 28,29 
Patient characteristics and socio-demographic variables can also influence the 
relative importance of attributes.22 Therefore, we included sex, age, education and health 
status as control variables. We distinguished three age groups (<26 years, 26 to 48 years 
and >48 years), three education levels (intermediate, A-Level and academic degree) and 
we measured current health status with a five-point Likert scale ranging from 1…very 
poor to 5…very good. Participants received a detailed explanation of all choice criteria 
to ensure a similar understanding of the constructs across patients (see Appendix for study 
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procedures). For example, innovativeness was described according to the six dimensions 
revealed in the pretest. 
Analytic Hierarchy Process (AHP) 
AHP is a widespread method in the health care context to measure patient 
preferences.1 The approach comprises four general steps: (1) problem modeling as 
hierarchy, (2) attribute comparison, (3) priority calculation, and (4) priority synthesis.30 
In this study, the five attributes measured belong to the same hierarchy level with 
the overarching goal of choosing the preferred hospital (step 1). Respondents compared 
paired attributes in a face-to-face interview or in an online survey and rated their preferred 
attribute in relation to the second attribute on a 9-point scale ranging from 1…equal 
importance to 9…extremely higher importance (step 2).31 We organized pairwise 
attribute comparisons of each participant in an upper triangular matrix, we completed the 
matrix with reciprocals and we calculated the vector of priorities for each respondent 
separately by solving for the principal eigenvector.31 We obtained the priority vector by 
an iterative matrix multiplication method (step 3).30,31  
We used the geometric mean for the aggregation of individual priorities (AIP). In 
contrast to the aggregation of individual judgment matrices in one combined group matrix 
(AIJ), AIP considers each individual separately and does not violate the Pareto Principle 
(step 4).32 Finally, because humans often judge inconsistently and may violate the 
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principle of transitivity, AHP suggests a consistency check with a standardized 
consistency ratio (CR).30,31  
However, since a modicum of inconsistency reflects a natural judgment and AHP 
allows for inconsistency,33 we did not exclude inconsistent data, but proved by group 
comparisons that no significant differences in priority weights between consistent and 
inconsistent data exists. In addition to AIP, we calculated the AIJ matrix. Under the 
premise of a sufficiently large data set (for a 5x5 matrix, the threshold is 25), the AIJ 
matrix is considered to be consistent regardless of the individual values of the consistency 
index when using the geometric mean.34 We show that priority values resulting from AIP 
and AIJ do not substantially differ and therefore ensure consistency of our aggregated 
results with both approaches.  
Conjoint Analysis (CA) 
CA realistically simulates trade-off decisions among multi-attribute alternatives.35 
We used traditional CA because it is time efficient, easily applicable and equally valid to 
other CA methods.36 The traditional CA in this study proceeded in four steps: (1) criteria 
identification, (2) stimuli generation, (3) stimuli ranking, and (4) priority calculation. 
After selecting five relevant hospital attributes and their corresponding two levels 
(step 1), we created stimuli (i.e., alternative hospitals) consisting of several attribute level 
combinations. Since including all possible attribute level combinations would lead to 
participant information overload (25=32 stimuli), we generated a fractional factorial 
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design using SPSS’s orthogonal design feature35. This type of design provides a subset of 
stimuli (step 2) that is large enough to estimate all parameters and ensures attribute 
balance and orthogonality of levels. For this case with five attributes and two levels per 
attribute, SPSS generated eight stimuli. Each participant subsequently rank-ordered the 
stimuli from one to eight in face-to-face interviews (step 3). Stimuli were displayed on 
separate cards and the order of the cards was randomized. 
For calculating relative attribute importance, we used metric model estimation. We 
used SPSS 22, which bases on ordinary least square (OLS) estimation, for calculating a 
common CA over all patients (step 4). We used both joint CA and individual aggregation 
average to explore any potential differences. Calculating correlations between the actual 
and predicted ranks using Kendall’s tau ensured accuracy of the results.35 
Group and Method Differences 
We decided to conduct non-parametric tests to calculate differences (Δ) between 
the relative importance of the attributes for different subgroups of our data, because of 
violation of the normality requirement (i.e., Kolmogorov-Smirnov test p<.001). For 
independent samples, we used Mann-Whitney-U tests (two subgroups) and Kruskal-
Wallis tests (more than two subgroups). For paired samples, we used the Wilcoxon test. 
Since some scholars argue for the robustness of parametric tests such as ANOVA and 
(paired) t-tests, we compared the results of the non-parametric and parametric tests. We 
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found only three significant differences in the 85 comparisons shown in Table 4 and Table 
5, indicating that the results are robust. 
RESULTS 
Quantitative Multi-Criteria Decision Making 
The quantitative study included 355 participants. Table 2 offers an overview of the 
demographic characteristics of the participants of the study. All chi-squared tests revealed 
no significant difference between AHP and CA participants in terms of age, gender, 
educational level and health status. 
__________________________ 
Insert Table 2 here 
__________________________ 
Attribute importance 
The relative importance of each of the attributes calculated by means of the two 
indirect methods (CA and AHP) and the direct method (constant sum scale) are shown in 
Table 3.  
For AIP, the results show that the most important attributes are recommendation 
with a relative importance of 30.6% (27.6-33.8) and quality information with a relative 
importance of 30.0% (27.0-33.4). Innovativeness is the third in the rank with 16.8% (14.8-
19.0). Waiting time and distance are fourth and fifth in rank with a relative importance of 
12.3% (11.1-13.7) and 10.3% (9.0-11.8) respectively. Calculations are based on both 
consistent (CR<0.1) and inconsistent (CR>0.1) data since the Mann-Whitney-U tests 
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revealed no differences in the relative importance of any of the attributes between groups 
of consistent respondents and those with inconsistent preferences. Likewise, the results 
do not differ between the face-to-face and online respondents (31.8% of the participants). 
The priority ranking also holds true for the aggregation of individual judgments (AIJ) 
(CR=.002), with only marginal differences in the relative importance, as reported in the 
fourth column of Table 3.  
__________________________ 
Insert Table 3 here 
__________________________ 
The analysis of joint CA data assigns the highest relative importance to quality 
information (31.8%) followed by recommendation (24.0%), distance (17.5%) and 
waiting time (15.1%). According to this method, innovativeness is the least important 
attribute (11.6%). Similarly to AHP, individually aggregated averages and joint CA 
calculations result in the same ranking despite minimal differences in the relative 
importance of each attribute. 
As for the constant sum scale, the ranking of attribute importance is as follows: 
recommendation (25.0%), quality information (24.4%), distance (18.3%), waiting time 
(16.9%) and innovativeness (15.4%). 
Group and Method Differences 
Group differences. We report differences across groups and methods in Table 4. 
The results show no significant differences in attribute importance across different age 
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groups, educational levels and health status. Significant differences between male and 
female respondents were found for waiting time, which was more important for men than 
women (mean male=16.1%, mean female=11.5%, P<.001).  
Method differences. AHP vs. CA. The results in the last two rows of Table 4 show 
the differences in attribute importance between respondents who participated in AHP and 
CA. The attribute importance reported by AHP and CA was significantly different for all 
attributes except quality information. AHP respondents assigned significantly higher 
importance to recommendation (mean AHP=28.6%, mean CA=22.4%, P<.001) and 
innovativeness (mean AHP=17.4%, mean CA=12.6%, P<.001). CA respondents assigned 
higher importance to distance (mean AHP=12.7%, mean CA=17.5%, P<.001) and 
waiting time (mean AHP=12.3%, mean CA=15.6%, P=.011).  
__________________________ 
Insert Table 4 here 
__________________________ 
Direct vs. indirect. In Table 5 we report the paired sample comparisons of attribute 
importance for direct and indirect methods. When taking into account the entire sample 
(i.e., AHP and CA respondents) we find that direct and indirect methods result in different 
importance levels for the attributes distance (mean indirect=15.1%, mean direct=18.3%, 
P<.001), waiting time (mean indirect=14.0%, mean direct=16.9%, P<.001) and quality 
information (mean indirect=30.3%, mean direct=24.4%, P<.001).  
__________________________ 
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Insert Table 5 here 
__________________________ 
DISCUSSION 
This research provides three distinct contributions to the field of health care services 
management. First, we conceptualize the patients’ perception of hospital innovativeness 
(i.e., innovativeness reputation). Second, we determine the relative importance of 
innovativeness reputation as a driver of patients’ hospital choice decisions. Third, we 
foster the discussion on multi-criteria decision making methods by providing new 
evidence on potential biases of AHP and CA. 
Research on organizational innovativeness, as the capability of a firm to create and 
use new products and services, has a long-standing tradition in innovation research.11 
However, research has mainly focused on the organizations’ internal perspective and on 
the hospitals’ adoption of technological or administrative innovations.5,6 The consumers’ 
perspective and external perceptions of the hospitals’ innovativeness (i.e., innovativeness 
reputation) are often neglected. While considering innovativeness from the internal 
perspective is especially relevant when evaluating the hospitals’ performance outcomes, 
the innovativeness reputation is important to attract new patients and increase sales. We 
found that participants associate a hospital’s innovativeness reputation with six different 
dimensions.  
Interestingly, the identified dimensions include the four dimensions of the 
consumer perception of health service quality.38 For example, ‘progressive work 
 21 
 
procedures’ reflect their technical quality dimension, ‘pleasant architecture’ their 
environment quality dimension, ‘efficient organization’ their administrative quality 
dimension and ‘competent staff’ their interpersonal quality dimension. Hence, the 
perception of quality constitutes a major aspect in the innovativeness reputation of 
hospitals as well. However, the conceptualization of innovativeness reputation 
additionally includes ‘value added services’ and ‘innovative stakeholder communication’ 
that seem to be unique to this construct. These findings reveal two aspects that are relevant 
to patients but have not been explored before. Value added services provide a fruitful 
ground for differentiation among health care competitors. While competing organizations 
mostly focus on the core dimensions of health service quality, value added services such 
as free Wi-Fi, fitness and wellness are ways to differentiate in a close competition at a 
comparably low-cost. Innovative stakeholder communication in the information age is 
the forefront of consumer relations and an important aspect of creating and 
communicating reputation.  
Furthermore, these two new aspects support our argument that innovativeness, as 
perceived by the patient, certainly goes beyond the technical aspects usually considered 
as organizational innovativeness, but also beyond broader conceptualizations and related 
constructs such as perceived service quality. In order to achieve a reputation for being 
innovative, hospitals must not only strive for quality, but also for additional novel 
approaches to service provision. Although the six dimensions might a priori not directly 
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correlate with traditional understandings of organizational innovativeness, we have 
shown that, in line with literature on consumers’ perception of innovativeness9,10, they all 
reflect novelty and provide benefits to patients.  
By using multiple multi-criteria decision making methods, we show that the so far 
disregarded role of innovativeness reputation is not to be neglected. Depending on the 
method of measurement, hospital innovativeness reputation accounts for 11.6% to 16.8% 
of the choice. For patients, it is as important as distance and waiting time, but not as 
important as recommendation and quality information. A holistic concept that aims to 
explain patients’ hospital choice behavior should therefore include innovativeness 
reputation as a determining construct. Although conventional wisdom and prior research 
on innovation adoption37 assumes that the importance of innovativeness is different 
across different consumer groups, this study demonstrates that demographic variables 
(age, gender, educational level and health status) are no suitable discriminators. 
Additionally, this research contributes to understanding methodological differences when 
exploring complex decisions. Comparing stated versus revealed preferences, this study 
shows that directly stated preferences overestimate the importance of distance and 
waiting time and, in turn, underestimate the importance of quality information. 
Accordingly, participants are probably not entirely aware of how their risk aversion 
influences the outcome in an actual choice setting. 
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Through the application of AHP (compositional) and CA (decompositional), we 
revealed structural variances in the evaluation of attributes. We find that the 
compositional method AHP relatively overestimates subjective criteria (i.e., 
recommendation, innovativeness) and the decompositional method CA relatively 
overestimates objective criteria (i.e., distance and waiting time). Following the thoughts 
of Kahneman (2003), this might be due to the large amount of information and the 
bounded rationality of decision-makers who face such situations.39 The cognitive burden 
is much higher in the realistic decision situation of CA23 than in the more abstract attribute 
comparison of AHP. The complex decision situation of CA prompts decision-makers to 
reduce the complexity by putting more emphasis on objective, measurable attributes. We 
expect the size of this effect to depend on the number of attributes: the more attributes 
(and hence the more complex the choice situation), the more will results of AHP and CA 
diverge.  
Nevertheless, we consider the results regarding innovativeness reputation to be 
reliable concerning the general tendency of its importance. Across all three methods (i.e., 
AHP, CA and constant sum scale) recommendation and quality information rank number 
one or two with a share of each far above 20%. Innovativeness, waiting time and quality 
information always rank third, fourth or fifth with shares below 20% but above 10%. 
Hence, differences in shares across the three methods for each criterion are not greater 
than 5%. Through the use of several methods we provide a range for the importance of 
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innovativeness reputation rather than a concrete number. This is necessary, due to the 
imperfection of each available method. Additional research is needed to determine the 
cause of this methodological variance.  
 
PRACTICAL IMPLICATIONS 
Although adopting and generating technological innovations influences hospital 
reputation from the patient perspective, the construct is much more multifaceted. Other 
important components of hospital innovativeness reputation are for example value added 
services (see Figure 1). Therefore, complementing core medical services with value 
added services can be effective in creating an innovative image and attracting patients. 
This seems especially important in situations, where we see a dense and homogenous 
competition among health care providers. Value added services such as free Wi-Fi, fitness 
or wellness facilities could be an important factor for differentiation from competitors 
that are perceived as equal in terms of their core medical service quality. In general, 
hospitals should consider all six hospital innovativeness reputation dimensions to build 
an innovative image. 
The finding that innovative reputation has a moderate influence on hospital choice 
(see Figure 1) has important managerial implications. Considering the limited resources 
of hospitals, the decision to invest in building a reputation for being innovative might 
provide a competitive advantage to the hospital but needs to be well reasoned. For 
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instance, investing in quality and in maintaining a network of trustworthy referring 
physicians seems to be more important for attracting patients. However, our study points 
to a series of services or measures that hospitals might implement at comparatively low 
investments and communicate externally to enhance their innovative reputation. For 
example, providing some of the value added services in Table 1 or minding the details 
that increase the pleasantness of the architecture does not require large investments in 
time and money. Nevertheless, these might play a role in building the hospital’s 
reputation for being innovative and hence yield significant returns on investment. 
Especially in the study context of Germany, but also in other western countries, ongoing 
challenges that lead to increasing health care costs require efficient hospital management 
and organization and effective resource allocation. Our results offer hospital managers a 
basis to compare investments in order to determine the most convenient strategies.   
Previous research38 found a significant impact of four health service quality 
dimensions on service satisfaction and behavioral intentions of patients. As already 
discussed, these dimensions overlap with four of our innovative hospital reputation 
dimensions. Therefore, we also expect that the dimensions to influence patients’ service 
satisfaction and enhance the likelihood that patients return for the next hospital stay. 
However, additional research would be needed to confirm the consequences of high 
innovative reputation on patient satisfaction and intentions. 
__________________________ 
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Insert Figure 1 here 
__________________________ 
 
LIMITATIONS AND FUTURE RESEARCH 
This study is not without limitations. First, our approach assumes an active choice 
decision. However, in a real decision context, patients might have a limited ability or 
willingness to use the available information or face restrictions of the health insurance 
system.22 Nevertheless, as the notion of the empowered patient becomes more salient in 
current health care reforms, providing patients with information is of high relevance.  
Second, we cannot exclude the possibility that other attributes such as ownership 
or hospital size17 might be important in the context of hospital choice as well. However, 
we included the most relevant attributes and demonstrate that innovativeness does not fall 
behind.  
Third, we did not find significant differences in the importance of hospital choice 
attributes for different groups of patients. However, the importance of different hospital 
innovativeness reputation dimensions could differ between groups of patients and should 
be investigated by future research. For example, patients that undergo routine 
interventions might not value competent staff as highly as patients with complex surgery 
procedures that require specific expertise and trust in the physician. Hence, future 
research should measure the importance of different innovative hospital reputation 
dimensions for different patient groups.  
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Fourth, the innovativeness dimensions are not necessarily as independent of other 
hospital attributes as assumed a priori. For example, progressive work procedures as 
hospital innovativeness reputation dimension could lower infection rates and therefore, 
relate to the attribute quality information. Moreover, effective organization as hospital 
innovativeness reputation dimension could reduce waiting times or in turn low waiting 
times could be a driver of hospital innovativeness reputation. However, such 
organizational dependencies are not primarily in the focus of the patients’ perspective. 
Fifth, AHP and CA both rely on hypothetical hospital settings. Hence, we did not 
investigate actual decisions. Therefore, future research could either retrospectively reveal 
choice determinants in actual hospital decisions or monitor and accompany in real time 
actual patient decisions.  
Sixth, we excluded prior experiences as a choice criteria in order to focus on the 
patients’ evaluation of a hospital’s reputation. Hence, the findings are only valid for 
patients who have not attended a hospital for surgery before. Further studies should 
include prior experiences as a hospital choice attribute in order to determine the impact 
of hospital innovativeness reputation on hospital choice in actual patient decisions.  
Finally, we uncovered differences in attribute importance for different methods. 
Future research should systematically study why the discrepancies across methods 
emerge and which differences systematically persist.  
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TABLES 
Table 1  
Dimensions of Hospital Innovativeness Reputation  
Dimension Definition 2nd order codes 1st order codes (related patient examples) Frequency n (%) 
1. 
Progressive 
work 
procedures 
High, up-to-date 
standards for 
patient treatment 
Modern and broad 
treatment methods 
Minimally invasive surgery, social workers, 
conventional medicine and alternative medicine, 
psychological support, health counseling 
87 (24.4%) 
High research orientation 
Presence of medical students and researchers, 
publication output, patents, R&D expenditures, 
research projects 
New technologies and 
medical devices 
Latest surgery material and MRT devices, use of 
tablets for flying visits, digital gait analysis 
Large interdisciplinary 
network 
Cooperation with health insurance firms, GPs and other 
hospitals, consulting of external specialists, many 
specialized centers (e.g., rehab, medical service 
centers) in one hospital 
High quality standards 
24-hour health care supply, high standards of hygiene, 
aftercare and convalescence in hospital, minimal 
misdiagnoses 
2. Value added services 
Non-treatment-
relevant services 
and facilities to 
enhance patient 
comfort 
Comfortable stay and 
entertainment options 
Free Wi-Fi and TV, fitness and wellness facilities, 
evening events, (baggage) transportation services, choir 
and reading circles, accommodations for visitors, 
flexible visiting hours, healthy and vegetarian meals 69 (19.4%) 
Additional treatment 
services 
Small number of beds in one room, seating facilities 
and recreation rooms, no bed placements in corridors 
after surgery 
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3. Pleasant architecture 
Non-treatment-
relevant design, 
ambience and 
infrastructure 
aspects 
Latest technical 
equipment 
Multimedia equipment, medication and food transport 
robots 
61 (17.1%) 
Contemporary interior 
design 
Intuitive corridor guidance, modern adjustable beds, 
transportable furniture, energy efficient architecture, 
large rooms 
Pleasant ambience 
No hospital ambience (dull corridors and typical 
hospital smell), modern staff dress code, daylight 
lamps, music 
Nice surroundings Parks, good transport connection, good location in the city, calm location 
4. Efficient organization 
Efficient internal 
organization of 
processes to 
support treatment 
Modern IT 
Digital data transfer and automatic administration 
systems, central information and communication 
technology, data security, information synchronization, 
short communication paths, digital patient file 
55 (15.4%) 
Efficient processes 
Interconnectedness between infirmaries, short waiting 
times, process-oriented spatial division, case 
management, clinical treatment pathways, supplier 
cooperation (e.g., laundry), flexibility and no 
formalization, central diagnosis, critical incident 
reporting system 
5. Competent staff 
Staff characteristics 
and behavior that 
enhance patient 
trust and comfort 
High expertise 
Up-to-date knowledge and continuous training, good 
qualifications, high degree of specialization, 
transparent communication about medication and 
treatment procedures, multiple informative dialogues  
50 (14.0%) Neat appearance Language expression, young age, pleasantness, motivated staff 
High patient-centeredness 
Shared-decision making, patient-as-customer attitude, 
consideration of patient wishes, equal treatment 
independent of insurance type, human-centeredness, 
personal and trustful relationship 
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6. 
Innovative 
stakeholder 
communication 
Hospital’s efforts 
to communicate 
transparently with 
its environment 
Good reputation 
Awards and certificates, recommendations from friends 
and GP, high reputation of staff and hospital, good 
hospital rankings 
34 (9.6%) Enough information 
provision 
Publication of research results for the public, open 
house days and information events, information 
material about hospital characteristics (e.g., number of 
operations) 
Easy information access Social media presence, modern and well-structured webpage, image movie, interactive location map 
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Table 2  
Demographic Characteristics of the Study Samples 
 AHP CA Difference 
(χ²-Test) 
Constant 
Sum Scale 
(Total) 
Sample Size 176 179  355 
Age  
[Mean (SD)] 38 (19) 40 (19) 
χ² = 4.106 
(P = 0.13) 39 (19) 
  <26 67 (38.1%) 52 (29.1%)  119 (33.5%) 
  26-48 59 (33.5%) 61 (34.1%)  120 (33.8%) 
  >48 50 (28.4%) 66 (36.9%)  116 (32.7%) 
Gender   χ² = 1.045 (P = 0.31)  
  Male 99 (56.3%) 91 (50.8%)  190 (53.5%) 
  Female 77 (43.7%) 88 (49.2%)  165 (46.5%) 
Educational Level   χ² = 3.222 (P = 0.20)  
  Intermediate 48 (27.3%) 52 (29.1%)  100 (28.2%) 
  A-Level 46 (26.1%) 31 (17.3%)  77 (21.7%) 
  Academic Degree 82 (46.6%) 88 (49.2%)  170 (47.9%) 
  Missing Values - 8 (4.5%)  8 (2.3%) 
Health Status 
[Mean (SD)] 3.81 (1.028) 3.91 (.958) 
χ² = 4.682 
(P = 0.32) 3.86 (.993) 
  1…very poor &  
  2…poor 20 (11.4%) 14 (7.8%) 
 34 (9.6%) 
  3…fair 30 (17.1%) 40 (22.4%)  70 (19.7%) 
  4…good 80 (45.5%) 71 (39.7%)  151 (42.5%) 
  5…very good 44 (25.0%) 54 (30.2%)  98 (27.6%) 
  Missing Values 2 (1.1%) -  2 (0.6%) 
Note. SD = Standard Deviation. AHP = Analytic Hierarchy Process.  
CA = Conjoint Analysis. 
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Table 3  
Relative Importance of Hospital Choice Attributes 
Note. AHP = Analytic Hierarchy Process. CA = Conjoint Analysis. CI = Confidence Interval. 
a Standardized geometric means. 
b 95% Confidence Interval. For AHP, CI is based on geometric mean. For CA as well as constant sum scale, CI is based on arithmetic mean. 
c Non-parametric Mann-Whitney-U test. No ANOVA as variance homogeneity is violated for innovativeness. The robust Welch test, which can 
be used when variance homogeneity is violated, shows also no significant differences (P = 0.70, P = 0.05, P = 0.81, P = 0.39, P = 0.05).
 AHPa CA Constant 
Sum Scale 
(Rank) 
[CI%]  
 AIP  
(Rank) 
[CI%]b 
AIJ  
(Rank) 
 
Differ-
ence 
Consistent  
(Rank)  
[CI%] 
n = 57   
Inconsistent  
(Rank) 
[CI%]  
n = 119 
Differ-
encec 
Individual 
Aggregation  
(Rank)  
[CI%] 
Joint 
CA 
(Rank) 
 
Differ-
ence 
Hospital 
Choice 
Attribute 
          
Distance 10.3% (5.) [9.0-11.8] 
10.2% 
(5.) Δ  -0.1%  
11.2% (5.) 
[8.86-14.11] 
  9.9% (5.) 
[8.29-11.75] 
Δ -1.3% 
(P = 0.22) 
17.5% (3.) 
[15.1-19.8] 
17.5% 
(3.) Δ +0.0% 
18.3% (3.) 
[16.9-19.7] 
Recommend-
ation 
30.6% (1.) 
[27.6-33.8] 
30.9% 
(1.) Δ +0.3%  
34.1% (1.) 
[28.50-40.78] 
28.9% (2.) 
[25.54-32.73] 
Δ -5.1% 
(P = 0.06) 
22.4% (2.) 
[19.8-25.0] 
24.0% 
(2.) Δ +1.6% 
25.0% (1.) 
[23.5-26.4] 
Waiting Time 12.3% (4.) [11.1-13.7] 
12.3% 
(4.) Δ  -0.1%  
12.5% (4.) 
[10.46-14.95] 
12.2% (4.) 
[10.68-14.00] 
Δ -0.3% 
(P = 0.87) 
15.6% (4.) 
[13.7-17.6] 
15.1% 
(4.) Δ -0.5% 
16.9% (4.) 
[15.9-17.8] 
Quality 
Information  
30.0% (2.) 
[27.0-33.4] 
30.1% 
(2.) Δ +0.1%  
27.2% (2.) 
[22.22-33.36] 
31.4% (1.) 
[27.64-35.58] 
Δ +4.1% 
(P = 0.42) 
31.9% (1.) 
[29.0-34.8] 
31.8% 
(1.) Δ -0.1% 
24.4% (2.) 
[22.99-25.8] 
Innovativeness 16.8% (3.) [14.8-19.0] 
16.5% 
(3.) Δ  -0.3%  
15.0% (3.) 
[12.47-18.12] 
17.6% (3.) 
[15.00-20.72] 
Δ +2.6% 
(P = 0.18) 
12.6% (5.) 
[10.6-14.5] 
11.6% 
(5.) Δ -1.0% 
15.5% (5.) 
[14.5-16.5] 
Quality 
Indicator           
CR - 0.002  < 0.1 > 0.1      
Kendall’s Tau       1.00*** 1.00***   
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Table 4  
Group Comparisons within Indirect Methods with Non-Parametric Tests  
Control Variable 
Indirect Method (individual AHP and CA combined) 
Mean (SD) 
Distance Recommend-ation 
Waiting 
Time 
Quality  
Information  
Innovative-
ness 
Age       
  <26 14.1 (15.0) 25.4 (16.5) 14.3 (11.5) 30.7 (17.2) 15.6 (14.5) 
  26-48 15.9 (15.8) 27.5 (16.6) 14.0 (10.5) 27.2 (17.3) 15.4 (13.8) 
  >48 15.4 (14.9) 23.4 (17.4) 13.7 (12.5) 33.0 (19.2) 14.5 (12.9) 
Gender      
  Male 14.3 (14.9) 25.3 (17.4) 16.1 (12.4)***  28.6 (17.5) 15.8 (14.2) 
  Female 16.1 (15.6) 25.7 (16.3) 11.5 (9.9)***  32.2 (18.5) 14.4 (13.2) 
Educational Level      
  Intermediate 16.4 (16.3) 25.6 (16.5) 12.7 (11.2) 30.1 (18.8) 15.2 (13.3) 
  A-Level 14.7 (15.8) 27.5 (16.3) 13.3 (11.7) 28.7 (18.5) 15.9 (15.2) 
  Academic    
  Degree 14.7 (14.5) 25.6 (17.0) 14.6 (11.6) 30.0 (17.0) 15.1 (13.4) 
Health Status      
  1…very poor &  
  2…poor 15.4 (17.9) 22.6 (18.8) 15.1 (15.2) 29.4 (18.6) 17.6 (15.2) 
  3…fair 16.6 (16.3) 28.2 (17.5) 14.2 (10.1) 25.8 (18.2) 15.2 (15.3) 
  4…good 14.1 (13.9) 25.6 (16.2) 13.6 (10.7) 31.4 (17.4) 15.2 (13.8) 
  5…very good 15.7 (15.7) 24.2 (16.7) 13.8 (12.0) 32.4 (18.3) 13.9 (12.0) 
Method      
  AHP 12.7 (14.1)*** 
28.6 
(15.4)*** 12.3 (9.5)* 28.6 (16.3) 
17.7 
(13.8)*** 
  CA 17.5 (15.9)*** 
22.4 
(17.6)*** 15.6 (13.0)* 31.9 (19.5) 
12.6 
(13.2)***  
Note. All numbers are in %. SD = Standard Deviation. AHP = Analytic Hierarchy Process.  
CA = Conjoint Analysis. 
*** P < 0.001 
**   P < 0.01 
*     P < 0.05 
 39 
 
Table 5  
Comparison between Direct and Indirect Methods with Wilcoxon-Test 
 Indirect Method Mean (SD) 
Direct Method 
Mean (SD) 
Total  
n = 355 
  
  Distance 15.1 (15.2)*** 18.3 (13.5)*** 
  Recommendation 25.5 (16.9) 25.0 (13.8) 
  Waiting Time 14.0 (11.5)*** 16.9 (9.5)*** 
  Quality Information  30.3 (18.0)*** 24.4 (13.9)*** 
  Innovativeness 15.1 (13.7) 15.5 (9.8) 
AHP  
n = 176   
  Distance 12.7 (14.1)*** 17.4 (13.4)*** 
  Recommendation 28.6 (15.5)*  26.6 (14.6)*  
  Waiting Time 12.3 (9.5)***  15.8 (9.5)***  
  Quality Information  28.6 (16.3)*** 24.3 (14.2)*** 
  Innovativeness 17.7 (13.8) 16.0 (10.1) 
CA  
n = 179   
  Distance 17.5 (15.9)* 19.1 (13.6)* 
  Recommendation 22.4 (17.6) 23.5 (12.9) 
  Waiting Time 15.6 (13.0)* 17.9 (9.5)* 
  Quality Information  31.9 (19.5)*** 24.4 (13.7)*** 
  Innovativeness 12.6 (13.2)*** 15.1 (9.6)*** 
Note. All numbers are in %. SD = Standard Deviation.  
AHP = Analytic Hierarchy Process. CA = Conjoint Analysis. 
*** P < 0.001 
**   P < 0.01 
*     P < 0.05 
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FIGURES 
 
 
 
Figure 1  Dimensions of Innovativeness Reputation and Hospital Choice 
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APPENDIX 
 
Survey Instrument (English Translation, Original in German) 
Master students participating in the data collection process were trained to conduct interviews 
and survey according to the instruments displayed below. Freedom was granted in minor 
aspects such as the choice of introductory sentences, the order of the pairwise comparisons in 
AHP or the display of the information on the stimuli cards for conjoint analysis. In addition, 
for the quantitative data collection students were allowed to use an online survey or a face-to-
face procedure. This freedom within pre-defined survey elements ensures a natural variation 
within the data collection procedure and prevents bias. The authors did not receive the full 
names or any other identifiers of the participants, which ensures maximum anonymity.  
 
For all participants: oral or written explanation of the five choice criteria 
 
 Distance: how far the next hospital is in terms of public transport time 
 Recommendation: recommended by the general practitioner or family and friends 
 Waiting time: waiting time for surgery after being placed on the waiting list 
 Quality information: comparative information about the infection rate 
 Innovativeness: how innovative is the hospital in terms of progressive work 
procedures, value added services, pleasant architecture, efficient organization, 
competent staff and innovative stakeholder communication 
 
Each participant either performed Analytic Hierarchy Process (AHP) or Conjoint Analysis 
(CA): 
 
Analytic Hierarchy Process (AHP) 
Rating of the following 10 pairwise comparisons according to the scale by Saaty 1987 (1… 
equal importance, 3… Moderate importance of one over another, 5… Essential or strong 
importance, 7… Very strong importance, 9… Extreme importance). The order of the 
combination varies and the left and the right side can be reversed. 
 
Distance 9 8 7 6 5 4 3 2 1 2 3 4 5 6 7 8 9 Recommend. 
Distance 9 8 7 6 5 4 3 2 1 2 3 4 5 6 7 8 9 Waiting time 
Distance 9 8 7 6 5 4 3 2 1 2 3 4 5 6 7 8 9 Quality information 
Distance 9 8 7 6 5 4 3 2 1 2 3 4 5 6 7 8 9 Innovativeness 
Recommend. 9 8 7 6 5 4 3 2 1 2 3 4 5 6 7 8 9 Waiting time 
Recommend. 9 8 7 6 5 4 3 2 1 2 3 4 5 6 7 8 9 Quality information 
Recommend. 9 8 7 6 5 4 3 2 1 2 3 4 5 6 7 8 9 Innovativeness 
Waiting time 9 8 7 6 5 4 3 2 1 2 3 4 5 6 7 8 9 Quality information 
Waiting time 9 8 7 6 5 4 3 2 1 2 3 4 5 6 7 8 9 Innovativeness 
Quality 
information 9 8 7 6 5 4 3 2 1 2 3 4 5 6 7 8 9 Waiting time 
 
Conjoint Analysis (CA) 
Display of the two criteria levels for each criterion. 
 
Criterion Level 1 Level 2 
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Distance Close < 30 minutes with public transport 
Far > 1.5 hours with public 
transport 
Recommendation Recommended Not recommended 
Waiting time Short < 2 month Long > 6 month 
Quality 
information Infection rate low < 1.8 % Infection rate high > 4.7 % 
Innovativeness High Low 
 
According to the orthogonal design, eight stimuli cards with the following information were 
created. The participants were asked to rank these cards according to their preference (1… most 
preferred, 8… last preferred). 
 
Stimuli Distance Recommend-ation Waiting Time 
Quality  
Information 
(Infection 
Rate) 
Innovat-
iveness 
1 Far  1.5 h Not recommend. Short  2 months Low  1.8% Low 
2 Close  30 min Not recommend. Long  6 months Low  1.8% Low 
3 Close  30 min Recommended Short  2 months Low  1.8% High 
4 Close  30 min Recommended Long  6 months High  4.7% Low 
5 Close  30 min Not recommend. Short  2 months High  4.7% High 
6 Far  1.5 h Recommended Long  6 months Low  1.8% High 
7 Far  1.5 h Not recommend. Long  6 months High  4.7% High 
8 Far  1.5 h Recommended Short  2 months High  4.7% Low 
 
 
All participants performed the constant sum scale task and provided information to be used 
as control variables: 
 
Constant Sum Scale 
What is the role of the single criteria for you when choosing a hospital? Please distribute of a 
total of 100% to all criteria. 
 Distance:   x % 
 Recommendation:  x % 
 Waiting time:  x % 
 Quality information:  x % 
 Innovativeness:  x % 
 Total =  100 % 
 
Control question: Are there any other relevant criteria not mentioned here? 
Control variables: 
 Please rate your perceived health status: 1… very poor 2… poor 3… fair 4… good 
5… very good 
 Gender: male, female 
 Age: in years 
 Educational level: intermediate, A-level, academic degree 
 
 
